| Year |
Citation |
Score |
| 2018 |
Kantarjian HM, Keating MJ, Freireich EJ. Toward the potential cure of leukemias in the next decade. Cancer. PMID 30291792 DOI: 10.1002/Cncr.31669 |
0.33 |
|
| 2018 |
Kantarjian HM, DiNardo CD, Nogueras-Gonzalez GM, Kadia TM, Jabbour E, Bueso-Ramos CE, O'Brien SM, Konopleva M, Jain NB, Daver NG, Shpall EJ, Champlin RE, Simkins A, Garcia-Manero G, Keating MJ, ... ... Freireich EJ, et al. Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000. Cancer. PMID 29645075 DOI: 10.1002/cncr.31370 |
0.321 |
|
| 2017 |
Aung F, DiNardo CD, Martinez F, Pierce S, Daver N, Kadia T, Jabbour E, Kantarjian H, Lichtiger B, Freireich EJ. Phase II Study of Prophylactic Non-Irradiated Granulocyte Transfusions in AML Patients Receiving Induction Chemotherapy Journal of Blood Disorders & Transfusion. 8. DOI: 10.4172/2155-9864.1000376 |
0.458 |
|
| 2016 |
Freireich E. Commentary on Thomas and Epstein: "Bone Marrow Transplantation in Acute Leukemia". Cancer Research. 76: 1301-2. PMID 26979789 DOI: 10.1158/0008-5472.Can-16-0366 |
0.32 |
|
| 2016 |
Aung FM, Bassett R, Lichtiger B, Freireich EJ. Comparison of Two Apheresis Instruments (Old vs. New) for Granulocyte Collection: A Single Institutional Experience Blood. 128: 5036-5036. DOI: 10.1182/Blood.V128.22.5036.5036 |
0.341 |
|
| 2015 |
Thompson PA, Tam CS, O'Brien SM, Wierda WG, Stingo F, Plunkett W, Smith SC, Kantarjian HM, Freireich EJ, Keating MJ. Fludarabine, cyclophosphamide and rituximab achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia. Blood. PMID 26492934 DOI: 10.1182/Blood-2015-09-667675 |
0.393 |
|
| 2015 |
Aung F, Freireich E, Lichtiger B. Does transfusion of aged red blood cells lead to adverse outcomes in Acute Myeloid Leukemia patients undergoing Hematopoietic stem cell Transplantation? Clinical Lymphoma Myeloma and Leukemia. 15: S179. DOI: 10.1016/J.Clml.2015.04.022 |
0.379 |
|
| 2014 |
Freireich EJ, Wiernik PH, Steensma DP. The leukemias: a half-century of discovery. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3463-9. PMID 25185093 DOI: 10.1200/Jco.2014.57.1034 |
0.326 |
|
| 2014 |
Aung FM, Lichtiger B, Bassett RL, Hosing C, Freireich EJ. Granulocyte concentrates from a single high-yield apheresis can be split to support multiple patients. Leukemia & Lymphoma. 55: 2577-83. PMID 24456072 DOI: 10.3109/10428194.2014.883619 |
0.363 |
|
| 2014 |
DiNardo CD, Aung FM, Martinez F, Daver N, Kadia T, Jain N, Jabbour E, Pemmaraju N, Reddy VM, Garcia-Manero G, Cortes J, Ravandi F, Kantarjian HM, Lichtiger B, Freireich EJ. A Phase II Feasibility Study of Prophylactic White Cell Transfusions for the Prevention of Infection in AML Patients Undergoing Induction Therapy Blood. 124: 1564-1564. DOI: 10.1182/BLOOD.V124.21.1564.1564 |
0.367 |
|
| 2013 |
Borthakur G, Rosenblum MG, Talpaz M, Daver N, Ravandi F, Faderl S, Freireich EJ, Kadia T, Garcia-Manero G, Kantarjian H, Cortes JE. Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies. Haematologica. 98: 217-21. PMID 22875630 DOI: 10.3324/Haematol.2012.071092 |
0.357 |
|
| 2013 |
Freireich EJ. History of acute leukemia Springer: New York. 171-175. DOI: 10.1007/978-1-4614-3764-2_13 |
0.442 |
|
| 2012 |
Freireich EJ. The history of leukemia therapy--a personal journey. Clinical Lymphoma, Myeloma & Leukemia. 12: 386-92. PMID 23158094 DOI: 10.1016/J.Clml.2012.09.014 |
0.321 |
|
| 2012 |
Freireich EJ, Lichtiger B, Mattiuzzi G, Martinez F, Reddy V, Kyle Wathen J. A prospective, randomized, double-blind study, comparing unirradiated to irradiated white blood cell transfusions in acute leukemia patients. Leukemia. 27: 861-5. PMID 23072780 DOI: 10.1038/Leu.2012.301 |
0.414 |
|
| 2012 |
Kadia TM, Kantarjian H, Kornblau S, Borthakur G, Faderl S, Freireich EJ, Luthra R, Garcia-Manero G, Pierce S, Cortes J, Ravandi F. Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS Cancer. 118: 5550-5559. PMID 22569880 DOI: 10.1002/Cncr.27596 |
0.333 |
|
| 2012 |
Hashmi G, Patel D, Zhang Y, Seul M, Aung FM, Cano P, Freireich EJ, Lichtiger B. Preventing Platelet Alloimmunization for Patients with Hematologic Malignancies: Rapid HLA-class I and HPA Immunogenetic Profiling to Enable Selection of Optimally Matched Platelets Blood. 120: 4691-4691. DOI: 10.1182/Blood.V120.21.4691.4691 |
0.35 |
|
| 2011 |
Cortés JE, Freireich EJ, Kantarjian H, Verstovsek S. Retrospect of hematologic malignancies 2010. Clinical Lymphoma, Myeloma & Leukemia. 11: S1. PMID 22035736 DOI: 10.1016/J.Clml.2011.05.038 |
0.315 |
|
| 2011 |
Duzkale H, Schweighofer CD, Coombes KR, Barron LL, Ferrajoli A, O'Brien S, Wierda WG, Pfeifer J, Majewski T, Czerniak BA, Jorgensen JL, Medeiros LJ, Freireich EJ, Keating MJ, Abruzzo LV. LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients. Blood. 117: 4076-84. PMID 21310924 DOI: 10.1182/blood-2010-09-304881 |
0.34 |
|
| 2011 |
Malik A, Bueso-Ramos C, Faderl S, Estey E, O'Brien S, Fernandez M, Nguyen M, Koller C, Freireich E, Beran M, Pierce S, Cortes J, Kantarjian H, Ravandi F. 510 Addition of All-Trans Retinoic Acid (ATRA) to the Combination of Fludarabine, Cytarabine, Idarubicin, With or Without GCSF in Older, Higher Risk Patients with AML and High-Risk MDS Does Not Improve the Outcome in Those with NPM1 Mutation Clinical Lymphoma Myeloma and Leukemia. 11: S128-S129. DOI: 10.1182/Blood.V120.21.2616.2616 |
0.415 |
|
| 2011 |
Quintás-Cardama A, Kantarjian H, Ravandi F, Garcia-Manero G, Faderl S, Sherry P, Brandt M, Borthakur G, Keating M, Freireich E, Cortes JE. Outcomes of Patients with Newly-Diagnosed Acute Myeloid Leukemia Over the Last 5 Decades At M.D. Anderson Cancer Center Blood. 118: 2606-2606. DOI: 10.1182/Blood.V118.21.2606.2606 |
0.383 |
|
| 2010 |
Kantarjian H, Ravandi F, O'Brien S, Cortes J, Faderl S, Garcia-Manero G, Jabbour E, Wierda W, Kadia T, Pierce S, Shan J, Keating M, Freireich EJ. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia. Blood. 116: 4422-9. PMID 20668231 DOI: 10.1182/Blood-2010-03-276485 |
0.396 |
|
| 2010 |
Verma D, Kantarjian H, Faderl S, O'Brien S, Pierce S, Vu K, Freireich E, Keating M, Cortes J, Ravandi F. Late relapses in acute myeloid leukemia: analysis of characteristics and outcome. Leukemia & Lymphoma. 51: 778-82. PMID 20196624 DOI: 10.3109/10428191003661852 |
0.395 |
|
| 2010 |
Golemovic M, Quintás-Cardama A, Manshouri T, Orsolic N, Duzkale H, Johansen M, Freireich EJ, Kantarjian H, Zingaro RA, Verstovsek S. MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells. Investigational New Drugs. 28: 402-12. PMID 19468689 DOI: 10.1007/S10637-009-9267-Z |
0.327 |
|
| 2009 |
Freireich EJ. The road to cancer control goes through leukemia research. Current Oncology. 16: 1-2. PMID 19862355 DOI: 10.3747/Co.V16I5.480 |
0.328 |
|
| 2009 |
Santos FPS, Faderl S, Garcia-Manero G, Koller C, Beran M, O'Brien S, Pierce S, Freireich EJ, Huang X, Borthakur G, Bueso-Ramos C, Lima Md, Keating M, Cortes J, Kantarjian H, et al. Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution Leukemia. 23: 2275-2280. PMID 19741728 DOI: 10.1038/Leu.2009.181 |
0.395 |
|
| 2009 |
Tsimberidou AM, Wen S, McLaughlin P, O'Brien S, Wierda WG, Lerner S, Strom S, Freireich EJ, Medeiros LJ, Kantarjian HM, Keating MJ. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 904-10. PMID 19114699 DOI: 10.1200/Jco.2008.17.5398 |
0.341 |
|
| 2009 |
Freireich EJ, Kurzrock R. The role of investigational therapy in management of patients with advanced metastatic malignancy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 304-6. PMID 19064962 DOI: 10.1200/Jco.2008.19.6543 |
0.36 |
|
| 2008 |
Kantarjian H, O'Brien S, Cortes J, Wierda W, Faderl S, Garcia-Manero G, Issa JP, Estey E, Keating M, Freireich EJ. Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years. Cancer. 113: 1933-52. PMID 18798533 DOI: 10.1002/Cncr.23655 |
0.436 |
|
| 2008 |
Tsimberidou AM, Kantarjian HM, Wen S, Keating MJ, O'Brien S, Brandt M, Pierce S, Freireich EJ, Medeiros LJ, Estey E. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer. 113: 1370-8. PMID 18623376 DOI: 10.1002/Cncr.23691 |
0.41 |
|
| 2008 |
Kantarjian H, O'Brien S, Ravandi F, Cortes J, Shan J, Bennett JM, List A, Fenaux P, Sanz G, Issa JP, Freireich EJ, Garcia-Manero G. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer. 113: 1351-61. PMID 18618511 DOI: 10.1002/Cncr.23697 |
0.365 |
|
| 2008 |
Tsimberidou AM, Kantarjian HM, Wen S, O'Brien S, Cortes J, Wierda WG, Koller C, Pierce S, Brandt M, Freireich EJ, Keating MJ, Estey EH. The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 721-30. PMID 18245532 DOI: 10.1158/1078-0432.Ccr-07-2063 |
0.392 |
|
| 2008 |
Verma D, Faderl S, O’Brien S, Pierce S, Cortes J, Vu K, Freireich E, Keating MJ, Kantarjian HM, Ravandi F. Late Relapses in Acute Myelogenous Leukemia: Analysis of Characteristics and Outcome. Blood. 112: 951-951. DOI: 10.1182/Blood.V112.11.951.951 |
0.434 |
|
| 2008 |
Mattiuzzi G, Greenberg E, Pierce S, Cortes J, Freireich E, O’Brien S, Kantarjian H. Relaxing the Protected Environment Has Not Adversely Impacted Early Outcome of Older Patients (≥ 50 years) with AML and HR- MDS Receiving Induction Therapy Blood. 112: 3988-3988. DOI: 10.1182/Blood.V112.11.3988.3988 |
0.327 |
|
| 2007 |
Tsimberidou AM, Wen S, O'Brien S, McLaughlin P, Wierda WG, Ferrajoli A, Faderl S, Manning J, Lerner S, Mai CV, Rodriguez AM, Hess M, Do KA, Freireich EJ, Kantarjian HM, et al. Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4648-56. PMID 17925562 DOI: 10.1200/Jco.2006.09.4508 |
0.407 |
|
| 2007 |
Atallah E, Cortes J, O'Brien S, Pierce S, Rios MB, Estey E, Markman M, Keating M, Freireich EJ, Kantarjian H. Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia. Blood. 110: 3547-51. PMID 17673605 DOI: 10.1182/Blood-2007-06-095844 |
0.443 |
|
| 2007 |
Verstovsek S, Giles F, Quintás-Cardama A, Perez N, Ravandi-Kashani F, Beran M, Freireich E, Kantarjian H. Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia? Hematological Oncology. 24: 181-8. PMID 16783836 DOI: 10.1002/Hon.787 |
0.356 |
|
| 2007 |
Alvarado Y, Kantarjian H, Freireich EJ, Garcia-Manero G, Ferrajoli A, Koller C, Estrov Z, Kornblau S, Laddie N, Smith L, Cortes J. Phase II dosing study of cytarabine chemotherapy in combination with cenersen (EL625) and idarubicin in refractory and relapsed acute myelogenous leukemia (AML) Journal of Clinical Oncology. 25: 7070-7070. DOI: 10.1200/jco.2007.25.18_suppl.7070 |
0.34 |
|
| 2007 |
Tsimberidou A, Kantarjian HM, Faderl S, Freireich EJ, Estey E. Exclusion from Acute Myeloid Leukemia (AML) Clinical Trials of Patients Unlikely To Respond. Blood. 110: 2867-2867. DOI: 10.1182/Blood.V110.11.2867.2867 |
0.362 |
|
| 2007 |
Tsimberidou AM, Kantarjian HM, Faderl S, Pierce S, Freireich EJ, Estey E. Untreated Patients with Acute Myeloid Leukemia, Age 50–59 Years and Performance Status 2 Should Be as Eligible for Targeted Therapy as Older Patients. Blood. 110: 2864-2864. DOI: 10.1182/Blood.V110.11.2864.2864 |
0.379 |
|
| 2006 |
Montero AJ, Estrov Z, Freireich EJ, Khouri IF, Koller CA, Kurzrock R. Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndrome. Leukemia & Lymphoma. 47: 2049-54. PMID 17071475 DOI: 10.1080/10428190600758058 |
0.352 |
|
| 2006 |
Tsimberidou AM, O'Brien S, Khouri I, Giles FJ, Kantarjian HM, Champlin R, Wen S, Do KA, Smith SC, Lerner S, Freireich EJ, Keating MJ. Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2343-51. PMID 16710033 DOI: 10.1200/Jco.2005.05.0187 |
0.411 |
|
| 2006 |
Ravandi F, Jorgensen JL, O'Brien SM, Verstovsek S, Koller CA, Faderl S, Giles FJ, Ferrajoli A, Wierda WG, Odinga S, Huang X, Thomas DA, Freireich EJ, Jones D, Keating MJ, et al. Eradication of minimal residual disease in hairy cell leukemia. Blood. 107: 4658-62. PMID 16497968 DOI: 10.1182/Blood-2005-11-4590 |
0.429 |
|
| 2006 |
Aribi AM, Kantarjian H, Estey E, Freireich E, Koller C, Thomas D, Kornblau S, Faderl S, Laddie N, Garcia-Manero G, Cortes J. Combination therapy with arsenic trioxide (ATO), all-trans retinoic acid (ATRA), and gemtuzumab ozogamycin (GO) in relapsed acute promyelocytic leukemia (APL) Journal of Clinical Oncology. 24: 6558-6558. DOI: 10.1200/Jco.2006.24.18_Suppl.6558 |
0.391 |
|
| 2006 |
Tsimberidou A, Kantarjian HM, Keating MJ, O’Brien S, Wen S, Cortes J, Giles F, Koller CA, Garcia-Manero G, Pierce S, Brandt M, Freireich EJ, Estey EH. Prognostic Significance of β-2 Microglobulin Levels in Acute Myeloid Leukemia: Analysis of 1293 Patients. Blood. 108: 802-802. DOI: 10.1182/Blood.V108.11.802.802 |
0.319 |
|
| 2006 |
Tsimberidou A, McLaughlin P, O’Brien S, Wen S, Wierda WG, Manning JT, Abruzzo LV, Lerner S, Hess MA, Kantarjian HM, Freireich EJ, Keating MJ. Genomic Aberrations in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma by Absolute Lymphocyte Count: Analysis of 1694 Patients. Blood. 108: 4958-4958. DOI: 10.1182/Blood.V108.11.4958.4958 |
0.346 |
|
| 2006 |
Tsimberidou A, O’Brien S, McLaughlin P, Wen S, Wierda W, Kantarjian HM, Manning J, Lerner S, Hess M, Freireich EJ, Keating MJ. Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Analysis of 2083 Patients. Blood. 108: 2790-2790. DOI: 10.1182/Blood.V108.11.2790.2790 |
0.382 |
|
| 2006 |
Tsimberidou A, McLaughlin P, O’Brien S, Wen S, Wierda WG, Manning J, Lerner S, Hess MA, Kantarjian H, Freireich EJ, Keating MJ. A Prognostic Score for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Analysis of 2189 Patients. Blood. 108: 2783-2783. DOI: 10.1182/Blood.V108.11.2783.2783 |
0.378 |
|
| 2005 |
Tsimberidou A, O’Brien S, Khouri I, Giles FJ, Kantarjian HM, Wen S, Smith SC, Lerner S, Freireich EJ, Keating MJ. Clinical Outcomes and Prognostic Factors in Patients with Richter’s Syndrome Treated with Chemotherapy and/or Immunotherapy with or without Stem Cell Transplantation. Blood. 106: 2097-2097. DOI: 10.1182/Blood.V106.11.2097.2097 |
0.408 |
|
| 2004 |
Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 101: 2788-801. PMID 15481055 DOI: 10.1002/Cncr.20668 |
0.374 |
|
| 2004 |
Sun X, Amin HM, Freireich EJ, Keating MJ, Kantarjian HM, Koller CA, O'Brien SM, Giles F, Albitar M. Hairy cell leukemia with large cells: long disease course with adequate response to therapy. Leukemia. 18: 1912-4. PMID 15385931 DOI: 10.1038/Sj.Leu.2403506 |
0.316 |
|
| 2004 |
Orsolic N, Giles FJ, Gourdeau H, Golemovic M, Beran M, Cortes J, Freireich EJ, Kantarjian H, Verstovsek S. Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluation. British Journal of Haematology. 124: 727-38. PMID 15009060 DOI: 10.1111/J.1365-2141.2004.04831.X |
0.354 |
|
| 2004 |
Amin HM, Pierce SA, Kantarjian HM, Keating MJ, Freireich EJ, Koller CA, Beran M, Albitar M, O’Brien SM, Estey EH. Increased Bone Marrow Erythroid Precursors Is Associated with Shorter Survival in Low-Grade Myelodysplastic Syndromes. Blood. 104: 2371-2371. DOI: 10.1182/Blood.V104.11.2371.2371 |
0.421 |
|
| 2004 |
Cheng X, Golemovic M, Giles F, Zingaro R, Gao M, Freireich EJ, Andreeff M, Kantarjian HM, Verstovsek S. Organic Arsenic Lipid Derivatives Are More Potent and Less Toxic Than Inorganic Arsenic Trioxide in Preclinical Testing. Blood. 104: 1803-1803. DOI: 10.1182/Blood.V104.11.1803.1803 |
0.337 |
|
| 2003 |
Rogers A, Joe Y, Manshouri T, Dey A, Jilani I, Giles F, Estey E, Freireich E, Keating M, Kantarjian H, Albitar M. Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia. Blood. 103: 2799-801. PMID 14576069 DOI: 10.1182/Blood-2003-06-1840 |
0.361 |
|
| 2003 |
Kurzrock R, Kantarjian HM, Cortes JE, Singhania N, Thomas DA, Wilson EF, Wright JJ, Freireich EJ, Talpaz M, Sebti SM. Farnesyltransferase inhibitor R115777 in myelodysplastic syndrome: clinical and biologic activities in the phase 1 setting. Blood. 102: 4527-34. PMID 12947010 DOI: 10.1182/Blood-2002-11-3359 |
0.333 |
|
| 2003 |
O'Brien S, Giles F, Talpaz M, Cortes J, Rios MB, Shan J, Thomas D, Andreeff M, Kornblau S, Faderl S, Garcia-Manero G, White K, Mallard S, Freireich E, Kantarjian HM. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase. Cancer. 98: 888-93. PMID 12942553 DOI: 10.1002/Cncr.11620 |
0.307 |
|
| 2003 |
Kantarjian H, O'Brien S, Cortes J, Giles F, Thomas D, Kornblau S, Shan J, Beth Rios M, Keating M, Freireich E, Talpaz M. Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications. Cancer. 98: 81-5. PMID 12833459 DOI: 10.1002/Cncr.11477 |
0.321 |
|
| 2003 |
Pearlman M, Jendiroba D, Pagliaro L, Keyhani A, Liu B, Freireich EJ, Travis E. Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity. Cancer Chemotherapy and Pharmacology. 52: 477-81. PMID 12827292 DOI: 10.1007/S00280-003-0655-3 |
0.772 |
|
| 2003 |
Duzkale H, Pagliaro LC, Rosenblum MG, Varan A, Liu B, Reuben J, Wierda WG, Korbling M, McMannis JD, Glassman AB, Scheinberg DA, Freireich EJ. Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGel. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 9: 364-72. PMID 12813444 DOI: 10.1016/S1083-8791(03)00129-0 |
0.365 |
|
| 2003 |
Kantarjian H, Gandhi V, Cortes J, Verstovsek S, Du M, Garcia-Manero G, Giles F, Faderl S, O'Brien S, Jeha S, Davis J, Shaked Z, Craig A, Keating M, Plunkett W, ... Freireich EJ, et al. Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia. Blood. 102: 2379-86. PMID 12791647 DOI: 10.1182/Blood-2003-03-0925 |
0.432 |
|
| 2003 |
Pearlman M, Jendiroba D, Pagliaro L, Keyhani A, Liu B, Freireich EJ. Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines. Leukemia Research. 27: 617-26. PMID 12681361 DOI: 10.1016/S0145-2126(02)00273-4 |
0.767 |
|
| 2003 |
Cortes J, Giles F, O'Brien S, Thomas D, Garcia-Manero G, Rios MB, Faderl S, Verstovsek S, Ferrajoli A, Freireich EJ, Talpaz M, Kantarjian H. Result of high-dose imatinib mesylate in patients with Philadelphia chromosome-positive chronic myeloid leukemia after failure of interferon-alpha. Blood. 102: 83-6. PMID 12637317 DOI: 10.1182/Blood-2003-01-0025 |
0.42 |
|
| 2002 |
Huh YO, Jilani I, Estey E, Giles F, Kantarjian H, Freireich E, Albitar M. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia. Leukemia. 16: 2249-2252. PMID 12399969 DOI: 10.1038/Sj.Leu.2402704 |
0.346 |
|
| 2002 |
Jilani I, Estey E, Huh Y, Joe Y, Manshouri T, Yared M, Giles F, Kantarjian H, Cortes J, Thomas D, Keating M, Freireich E, Albitar M. Differences in CD33 intensity between various myeloid neoplasms. American Journal of Clinical Pathology. 118: 560-6. PMID 12375643 DOI: 10.1309/1Wmw-Cmxx-4Wn4-T55U |
0.303 |
|
| 2002 |
Albitar M, Manshouri T, Shen Y, Liu D, Beran M, Kantarjian HM, Rogers A, Jilani I, Lin CW, Pierce S, Freireich EJ, Estey EH. Myelodysplastic syndrome is not merely "preleukemia". Blood. 100: 791-8. PMID 12130488 DOI: 10.1182/Blood.V100.3.791 |
0.407 |
|
| 2002 |
Jendiroba DB, Klostergaard J, Keyhani A, Pagliaro L, Freireich EJ. Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosine. Leukemia Research. 26: 301-10. PMID 11792420 DOI: 10.1016/S0145-2126(01)00129-1 |
0.777 |
|
| 2002 |
Giles FJ, Shen Y, Kantarjian HM, Korbling MJ, O'Brien S, Anderlini P, Donato M, Pierce S, Keating MJ, Freireich EJ, Estey E. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival. Leukemia & Lymphoma. 42: 67-73. PMID 11699223 DOI: 10.3109/10428190109097677 |
0.38 |
|
| 2001 |
Estey E, Koller C, Cortes J, Reed P, Freireich E, Giles F, Kantarjian H. Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid. Leukemia & Lymphoma. 42: 309-316. PMID 11699395 DOI: 10.3109/10428190109064587 |
0.378 |
|
| 2001 |
Freireich EJ. Can we conquer cancer in the twenty-first century? Cancer Chemotherapy and Pharmacology. S4-10. PMID 11587365 DOI: 10.1007/S002800100298 |
0.317 |
|
| 2001 |
Verstovsek S, Kantarjian H, Aguayo A, Manshouri T, Freireich E, Keating M, Estey E, Albitar M. Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome. British Journal of Haematology. 114: 290-5. PMID 11529846 DOI: 10.1046/J.1365-2141.2001.02921.X |
0.403 |
|
| 2001 |
Verstovsek S, Kantarjian H, Estey E, Aguayo A, Giles FJ, Manshouri T, Koller C, Estrov Z, Freireich E, Keating M, Albitar M. Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome. Leukemia. 15: 1165-70. PMID 11480557 DOI: 10.1038/Sj.Leu.2402182 |
0.393 |
|
| 2001 |
Keyhani A, Jendiroba DB, Freireich EJ. Angiogenesis and leukemia Leukemia Research. 25: 639-645. PMID 11397467 DOI: 10.1016/S0145-2126(00)00161-2 |
0.756 |
|
| 2001 |
Kurzrock R, Bueso-Ramos CE, Kantarjian H, Freireich E, Tucker SL, Siciliano M, Pilat S, Talpaz M. BCR rearrangement-negative chronic myelogenous leukemia revisited. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 2915-26. PMID 11387365 DOI: 10.1200/Jco.2001.19.11.2915 |
0.326 |
|
| 2001 |
O’Brien SM, Kantarjian H, Thomas DA, Giles FJ, Freireich EJ, Cortes J, Lerner S, Keating MJ. Rituximab Dose-Escalation Trial in Chronic Lymphocytic Leukemia Journal of Clinical Oncology. 19: 2165-2170. PMID 11304768 DOI: 10.1200/Jco.2001.19.8.2165 |
0.349 |
|
| 2000 |
FREIREICH EJ, SCHMIDT PJ, SCHNEIDERMAN MA, FREI E. A comparative study of the effect of transfusion of fresh and preserved whole blood on bleeding in patients with acute leukemia. The New England Journal of Medicine. 260: 6-11. PMID 13613493 DOI: 10.1056/Nejm195901012600102 |
0.376 |
|
| 2000 |
TOBIE JE, EDGCOMB JH, FREIREICH EJ. Tongue worm (Linguatula serrata) infestation in a patient with acute leukemia. American Journal of Clinical Pathology. 28: 628-33. PMID 13508581 DOI: 10.1093/Ajcp/28.6.628 |
0.418 |
|
| 2000 |
Jendiroba DB, Freireich EJ. Granulocyte transfusions: from neutrophil replacement to immunereconstitution. Blood Reviews. 14: 219-27. PMID 11124109 DOI: 10.1054/blre.2000.0134 |
0.739 |
|
| 2000 |
Ravandi-Kashani F, O'Brien S, Manshouri T, Lerner S, Sim S, Dodd K, Kantarjian H, Freireich E, Keating M, Albitar M. Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia. Leukemia Research. 24: 469-74. PMID 10781679 DOI: 10.1016/S0145-2126(00)00008-4 |
0.371 |
|
| 2000 |
Huh YO, Smith TL, Collins P, Bueso-Ramos C, Albitar M, Kantarjian HM, Pierce SA, Freireich EJ. Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry. Leukemia & Lymphoma. 37: 319-31. PMID 10752983 DOI: 10.3109/10428190009089432 |
0.356 |
|
| 2000 |
Keating MJ, Smith TL, Lerner S, O'Brien S, Robertson LE, Kantarjian H, Freireich EJ. Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemia. Leukemia & Lymphoma. 37: 71-85. PMID 10721771 DOI: 10.3109/10428190009057630 |
0.342 |
|
| 2000 |
Keyhani A, Huh YO, Jendiroba D, Pagliaro L, Cortez J, Pierce S, Pearlman M, Estey E, Kantarjian H, Freireich EJ. Increased CD38 expression is associated with favorable prognosis in adult acute leukemia. Leukemia Research. 24: 153-9. PMID 10654451 DOI: 10.1016/S0145-2126(99)00147-2 |
0.761 |
|
| 2000 |
Sacchi S, Kantarjian HM, Freireich EJ, O'Brien S, Cortes J, Rios MB, Kornblau S, Giles FJ, Koller C, Gajewski J, Talpaz M. Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia. Leukemia & Lymphoma. 35: 483-9. PMID 10609785 DOI: 10.1080/10428199909169612 |
0.379 |
|
| 2000 |
Aguayo A, Kantarjian HM, Manshouri T, Gidel C, Estey E, Thomas D, Koller C, Estrov Z, O'Brien S, Keating M, Freireich E, Albitar M. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood. 96: 2240-2245. DOI: 10.1182/Blood.V96.6.2240.H8002240_2240_2245 |
0.313 |
|
| 1999 |
Starostik P, O'Brien S, Chung CY, Haidar M, Manshouri T, Kantarjian H, Freireich E, Keating M, Albitar M. The prognostic significance of 13q14 deletions in chronic lymphocytic leukemia Leukemia Research. 23: 795-801. PMID 10475618 DOI: 10.1016/S0145-2126(99)00088-0 |
0.355 |
|
| 1999 |
Weinkauff R, Estey EH, Starostik P, Hayes K, Huh YO, Hirsch-Ginsberg C, Andreeff M, Keating M, Kantarjian HM, Freireich EJ, Albitar M. Use of peripheral blood blasts vs bone marrow blasts for diagnosis of acute leukemia. American Journal of Clinical Pathology. 111: 733-40. PMID 10361507 DOI: 10.1093/Ajcp/111.6.733 |
0.385 |
|
| 1999 |
Estey EH, Thall PF, Pierce S, Cortes J, Beran M, Kantarjian H, Keating MJ, Andreeff M, Freireich E. Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin ± all-trans retinoic acid ± granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome Blood. 93: 2478-2484. PMID 10194425 DOI: 10.1182/Blood.V93.8.2478.408K04_2478_2484 |
0.378 |
|
| 1999 |
Cortes JE, Kantarjian HM, O'Brien S, Giles F, Keating MJ, Freireich EJ, Estey EH. A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission. Cancer. 85: 1506-13. PMID 10193940 DOI: 10.1002/(Sici)1097-0142(19990401)85:7<1506::Aid-Cncr11>3.0.Co;2-O |
0.364 |
|
| 1999 |
Albitar M, Manshouri T, Kantarjian H, Keating M, Estrov Z, Faber J, Freireich EJ, Pierce S, Estey E. Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia. Leukemia Research. 23: 63-9. PMID 9933137 DOI: 10.1016/S0145-2126(98)00132-5 |
0.314 |
|
| 1999 |
Estey EH, Giles FJ, Kantarjian H, O’Brien S, Cortes J, Freireich EJ, Lopez-Berestein G, Keating M. Molecular Remissions Induced by Liposomal-Encapsulated All-Trans Retinoic Acid in Newly Diagnosed Acute Promyelocytic Leukemia Blood. 94: 2230-2235. DOI: 10.1182/Blood.V94.7.2230.419K05_2230_2235 |
0.397 |
|
| 1999 |
O’Brien S, Kantarjian H, Koller C, Feldman E, Beran M, Andreeff M, Giralt S, Cheson B, Keating M, Freireich E, Rios MB, Talpaz M. Sequential Homoharringtonine and Interferon- in the Treatment of Early Chronic Phase Chronic Myelogenous Leukemia Blood. 93: 4149-4153. DOI: 10.1182/Blood.V93.12.4149.412K10_4149_4153 |
0.409 |
|
| 1998 |
GAYDOS LA, FREIREICH EJ, MANTEL N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. The New England Journal of Medicine. 266: 905-9. PMID 13897369 DOI: 10.1056/Nejm196205032661802 |
0.416 |
|
| 1998 |
FREIREICH EJ. Factors influencing patient selection for chemotherapy studies of acute leukemia. Journal of Chronic Diseases. 15: 251-7. PMID 13894984 DOI: 10.1016/0021-9681(62)90007-3 |
0.43 |
|
| 1998 |
FREIREICH EJ, GEHAN EA, SULMAN D, BOGGS DR, FREI E. The effect of chemotherapy on acute leukemia in the human. Journal of Chronic Diseases. 14: 593-608. PMID 13894982 DOI: 10.1016/0021-9681(61)90118-7 |
0.439 |
|
| 1998 |
Cortes J, Talpaz M, O'Brien S, Rios MB, Majlis A, Keating M, Freireich EJ, Kantarjian H. Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 3279-85. PMID 9779702 DOI: 10.1200/Jco.1998.16.10.3279 |
0.361 |
|
| 1998 |
Jendiroba DB, Lichtiger B, Anaissie E, Reddy V, O'Brien S, Kantarjian H, Freireich EJ. Evaluation and comparison of three mobilization methods for the collection of granulocytes. Transfusion. 38: 722-8. PMID 9709779 DOI: 10.1046/J.1537-2995.1998.38898375510.X |
0.756 |
|
| 1998 |
Keating MJ, O'Brien S, Lerner S, Koller C, Beran M, Robertson LE, Freireich EJ, Estey E, Kantarjian H. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood. 92: 1165-1171. DOI: 10.1182/Blood.V92.4.1165.416K03_1165_1171 |
0.444 |
|
| 1997 |
Estey E, deLima M, Strom S, Pierce S, Freireich EJ, Keating MJ. Long-term follow-up of patients with newly diagnosed acute myeloid leukemia treated at the University of Texas M.D. Anderson Cancer Center. Cancer. 80: 2176-80. PMID 9395030 DOI: 10.1002/(Sici)1097-0142(19971201)80:11+<2176::Aid-Cncr2>3.0.Co;2-G |
0.414 |
|
| 1997 |
Dignani MC, Anaissie EJ, Hester JP, O'Brien S, Vartivarian SE, Rex JH, Kantarjian H, Jendiroba DB, Lichtiger B, Andersson BS, Freireich EJ. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia. 11: 1621-30. PMID 9324280 DOI: 10.1038/Sj.Leu.2400811 |
0.778 |
|
| 1997 |
Freireich EJ. The road to the cure of acute lymphoblastic leukemia: a personal perspective. Oncology. 54: 265-9. PMID 9216848 DOI: 10.1159/000227700 |
0.345 |
|
| 1997 |
de Lima M, Strom SS, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich E, Estey E. Implications of Potential Cure in Acute Myelogenous Leukemia: Development of Subsequent Cancer and Return to Work Blood. 90: 4719-4724. DOI: 10.1182/Blood.V90.12.4719 |
0.398 |
|
| 1996 |
BODEY GP, NIES BA, MOHBERG NR, FREIREICH EJ. THE EFFECT OF ADRENAL CORTICOSTEROID THERAPY ON INFECTIONS IN ACUTE LEUKEMIA. The American Journal of the Medical Sciences. 250: 162-7. PMID 14331946 DOI: 10.1097/00000441-196508000-00006 |
0.34 |
|
| 1996 |
BODEY GP, NIES BA, FREIREICH EJ. MULTIPLE ORGANISM SEPTICEMIA IN ACUTE LEUKEMIA; ANALYSIS OF 54 EPISODES. Archives of Internal Medicine. 116: 266-72. PMID 14315659 DOI: 10.1001/Archinte.1965.03870020106019 |
0.364 |
|
| 1996 |
HERSH EM, BODEY GP, NIES BA, FREIREICH EJ. CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963. Jama. 193: 105-9. PMID 14304351 DOI: 10.1001/Jama.1965.03090020019005 |
0.346 |
|
| 1996 |
FREIREICH EJ. SUPPORTIVE THERAPY IN ACUTE LEUKEMIA. Ca: a Cancer Journal For Clinicians. 14: 257-60. PMID 14216116 DOI: 10.3322/Canjclin.14.6.257 |
0.346 |
|
| 1996 |
ROTHMAN AR, CARBONE PP, RIESELBACH R, FREIREICH EJ. PAPER ELECTROPHORESIS OF CEREBROSPINAL FLUID PROTEINS IN PATIENTS WITH MENINGEAL LEUKEMIA. Cancer. 17: 798-802. PMID 14176995 DOI: 10.1002/1097-0142(196406)17:6<798::Aid-Cncr2820170618>3.0.Co;2-I |
0.305 |
|
| 1996 |
LEVIN RH, BARRETT PV, CLINE MJ, BERLIN NI, FREIREICH EJ. PLATELET THERAPY AND RED CELL DEFECT IN APLASTIC ANEMIA. Archives of Internal Medicine. 114: 278-83. PMID 14160122 DOI: 10.1001/Archinte.1964.03860080128013 |
0.34 |
|
| 1996 |
LEVIN RH, WHANG J, TJIO JH, CARBONE PP, FREI E, FREIREICH EJ. PERSISTENT MITOSIS OF TRANSFUSED HOMOLOGOUS LEUKOCYTES IN CHILDREN RECEIVING ANTILEUKEMIC THERAPY. Science (New York, N.Y.). 142: 1305-11. PMID 14074844 DOI: 10.1126/Science.142.3597.1305 |
0.401 |
|
| 1996 |
FREIREICH EJ, KLIMAN A, GAYDOS LA, MANTEL N, FREI E. RESPONSE TO REPEATED PLATELET TRANSFUSION FROM THE SAME DONOR. Annals of Internal Medicine. 59: 277-87. PMID 14065945 DOI: 10.7326/0003-4819-59-3-277 |
0.302 |
|
| 1996 |
Hester JP, Dignani MC, Anaissie EJ, Kantarjian HM, O'Brien S, Freireich EJ. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. Journal of Clinical Apheresis. 10: 188-93. PMID 8770711 DOI: 10.1002/Jca.2920100406 |
0.379 |
|
| 1996 |
Cortes JE, Kantarjian H, Freireich EJ. Acute lymphocytic leukemia: a comprehensive review with emphasis on biology and therapy. Cancer Treatment and Research. 84: 291-323. PMID 8724635 DOI: 10.1007/978-1-4613-1261-1_13 |
0.341 |
|
| 1996 |
Ghaddar HM, Pierce S, Kantarjian HM, Freireich EJ, Keating MJ, Estey EH. Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia. Leukemia & Lymphoma. 22: 71-6. PMID 8724530 DOI: 10.3109/10428199609051730 |
0.432 |
|
| 1995 |
Cortes J, O'Brien SM, Pierce S, Keating MJ, Freireich EJ, Kantarjian HM. The Value of High-Dose Systemic Chemotherapy and Intrathecal Therapy for Central Nervous System Prophylaxis in Different Risk Groups of Adult Acute Lymphoblastic Leukemia Blood. 86: 2091-2097. DOI: 10.1182/Blood.V86.6.2091.Bloodjournal8662091 |
0.347 |
|
| 1994 |
Seymour J, Kurzrock R, Freireich E, Estey E. 2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia Blood. 83: 2906-2911. DOI: 10.1182/Blood.V83.10.2906.2906 |
0.374 |
|
| 1993 |
Giralt S, Escudier S, Kantarjian H, Deisseroth A, Freireich EJ, Andersson BS, O'Brien S, Andreeff M, Fisher H, Cork A. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. The New England Journal of Medicine. 329: 757-61. PMID 7688862 DOI: 10.1056/Nejm199309093291103 |
0.335 |
|
| 1993 |
Freireich EJ. Treatment of malignancies, past and present. Hospital Practice (Office Ed.). 28: 109-13, 116, 122-6. PMID 7680350 DOI: 10.1080/21548331.1993.11442767 |
0.321 |
|
| 1993 |
Keating MJ, O'Brien S, Kantarjian H, Plunkett W, Estey E, Koller C, Beran M, Freireich EJ. Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood. 81: 2878-2884. DOI: 10.1182/Blood.V81.11.2878.Bloodjournal81112878 |
0.436 |
|
| 1992 |
Freireich EJ. Prevention of chemotherapy-induced leukemia and of leukemia relapses. Medical Oncology and Tumor Pharmacotherapy. 8: 155-8. PMID 1725055 DOI: 10.1007/BF02987173 |
0.338 |
|
| 1992 |
Lee M, Kantarjian H, Talpaz M, Freireich E, Deisseroth A, Trujillo J, Stass S. Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy Blood. 79: 1920-1923. DOI: 10.1182/Blood.V79.8.1920.1920 |
0.361 |
|
| 1992 |
Chang K, Wang G, Freireich E, Daly M, Naylor S, Trujillo J, Stass S. Specific expression of the annexin VIII gene in acute promyelocytic leukemia Blood. 79: 1802-1810. DOI: 10.1182/Blood.V79.7.1802.1802 |
0.306 |
|
| 1991 |
Lotzová E, Savary CA, Totpal K, Schachner J, Lichtiger B, McCredie KB, Freireich EJ. Highly oncolytic adherent lymphocytes: therapeutic relevance for leukemia. Leukemia Research. 15: 245-54. PMID 2030606 DOI: 10.1016/0145-2126(91)90127-F |
0.303 |
|
| 1991 |
Kantarjian HM, Talpaz M, Keating MJ, Estey EH, O'Brien S, Beran M, McCredie KB, Gutterman J, Freireich EJ. Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Cancer. 68: 1201-7. PMID 1873771 DOI: 10.1002/1097-0142(19910915)68:6<1201::Aid-Cncr2820680604>3.0.Co;2-1 |
0.401 |
|
| 1991 |
Kurzrock R, Talpaz M, Gomez JA, Estey EH, O'Brien S, Hirsch-Ginsberg C, Koller C, Freireich EJ, Gutterman JU. Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patients. British Journal of Haematology. 78: 352-8. PMID 1873220 DOI: 10.1111/J.1365-2141.1991.Tb04448.X |
0.388 |
|
| 1991 |
Keating MJ, Kantarjian H, O'Brien S, Koller C, Talpaz M, Schachner J, Childs CC, Freireich EJ, McCredie KB. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 9: 44-9. PMID 1702145 DOI: 10.1200/Jco.1991.9.1.44 |
0.385 |
|
| 1990 |
Kantarjian HM, Walters RL, Keating MJ, Estey EH, O'Brien S, Schachner J, McCredie KB, Freireich EJ. Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia. Cancer. 65: 5-8. PMID 2293869 DOI: 10.1002/1097-0142(19900101)65:1<5::Aid-Cncr2820650104>3.0.Co;2-R |
0.462 |
|
| 1990 |
Walters R, Kantarjian HM, Keating MJ, Estey EH, Trujillo J, Cork A, McCredie KB, Freireich EJ. The importance of cytogenetic studies in adult acute lymphocytic leukemia. The American Journal of Medicine. 89: 579-87. PMID 2239977 DOI: 10.1016/0002-9343(90)90175-D |
0.352 |
|
| 1990 |
Keating MJ, Hester JP, Mccredie KB, Burgess MA, Murphy WK, Freireich EJ. Long-term results of CAP therapy in chronic lymphocytic leukemia Leukemia and Lymphoma. 2: 391-397. DOI: 10.3109/10428199009069292 |
0.424 |
|
| 1990 |
Kantarjian H, Hirsch-Ginsberg C, Yee G, Huh Y, Freireich E, Stass S. Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy [see comments] Blood. 76: 808-813. DOI: 10.1182/Blood.V76.4.808.Bloodjournal764808 |
0.387 |
|
| 1990 |
Estey E, Dixon D, Kantarjian H, Keating M, McCredie K, Bodey G, Kurzrock R, Talpaz M, Freireich E, Deisseroth A. Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony- stimulating factor Blood. 75: 1766-1769. DOI: 10.1182/Blood.V75.9.1766.Bloodjournal7591766 |
0.421 |
|
| 1989 |
Kantarjian HM, Keating MJ, Walters RS, Koller CA, McCredie KB, Freireich EJ. Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia. Cancer. 63: 813-7. PMID 2914287 DOI: 10.1002/1097-0142(19890301)63:5<813::Aid-Cncr2820630502>3.0.Co;2-V |
0.436 |
|
| 1989 |
Keating MJ, Kantarjian H, Smith TL, Estey E, Walters R, Andersson B, Beran M, McCredie KB, Freireich EJ. Response to salvage therapy and survival after relapse in acute myelogenous leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 7: 1071-80. PMID 2666590 DOI: 10.1200/Jco.1989.7.8.1071 |
0.422 |
|
| 1989 |
Kantarjian HM, Walters RS, Keating MJ, Barlogie B, McCredie KB, Freireich EJ. Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia. Cancer. 64: 16-22. PMID 2659160 DOI: 10.1002/1097-0142(19890701)64:1<16::Aid-Cncr2820640104>3.0.Co;2-O |
0.467 |
|
| 1989 |
Maddox AM, Keating MJ, Freireich EJ, Haddox MK. Mononuclear cell polyamine content associated with myeloid maturation in patients with leukemia during administration of polyamine inhibitors. Investigational New Drugs. 7: 119-29. PMID 2507470 DOI: 10.1007/Bf00170848 |
0.405 |
|
| 1989 |
Gagnon G, Childs C, LeMaistre A, Keating M, Cork A, Trujillo J, Nellis K, Freireich E, Stass S. Molecular heterogeneity in acute leukemia lineage switch Blood. 74: 2088-2095. DOI: 10.1182/Blood.V74.6.2088.Bloodjournal7462088 |
0.337 |
|
| 1989 |
Cason J, Trujillo J, Estey E, Huh Y, Freireich E, Stass S. Peripheral acute leukemia: high peripheral but low-marrow blast count Blood. 74: 1758-1761. DOI: 10.1182/Blood.V74.5.1758.Bloodjournal7451758 |
0.445 |
|
| 1989 |
Keating M, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich E, McCredie K. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia Blood. 74: 19-25. DOI: 10.1182/Blood.V74.1.19.19 |
0.39 |
|
| 1988 |
Kantarjian HM, Keating MJ, Walters RS, McCredie KB, Freireich EJ. The characteristics and outcome of patients with late relapse acute myelogenous leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 6: 232-8. PMID 3276823 DOI: 10.1200/Jco.1988.6.2.232 |
0.401 |
|
| 1988 |
Kantarjian HM, Shtalrid M, Kurzrock R, Blick M, Dalton WT, LeMaistre A, Stass SA, McCredie KB, Gutterman J, Freireich EJ. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. The American Journal of Medicine. 85: 639-44. PMID 3189367 DOI: 10.1016/S0002-9343(88)80235-3 |
0.373 |
|
| 1988 |
Walters RS, Kantarjian HM, Keating MJ, Plunkett WK, Estey EH, Andersson B, Beran M, McCredie KB, Freireich EJ. Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia. Cancer. 62: 677-82. PMID 3165047 DOI: 10.1002/1097-0142(19880815)62:4<677::Aid-Cncr2820620405>3.0.Co;2-B |
0.445 |
|
| 1988 |
Kantarjian HM, Walters RS, Keating MJ, Talpaz M, Andersson B, Beran M, McCredie KB, Freireich EJ. Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinoside. Cancer. 62: 672-6. PMID 3165046 DOI: 10.1002/1097-0142(19880815)62:4<672::Aid-Cncr2820620404>3.0.Co;2-T |
0.441 |
|
| 1988 |
Maddox AM, Keating MJ, Freireich EJ, Haddox MK. Polyamines increase in human peripheral blood and bone marrow mononuclear cells following administration of methylglyoxal bis(guanylhydrazone). Chemotherapy. 34: 419-29. PMID 3141118 DOI: 10.1159/000238602 |
0.382 |
|
| 1988 |
Keating MJ, Estey E, Kantarjian HM, Walters R, Smith T, McCredie KB, Freireich EJ. Comparison of results of salvage therapy in adult acute myelogenous leukemia. Acta Haematologica. 120-6. PMID 3124434 DOI: 10.1159/000205916 |
0.424 |
|
| 1988 |
Kantarjian HM, Talpaz M, Kurzrock R, Keating MJ, McCredie KB, Gutterman J, Freireich EJ. Intensive combination chemotherapy and interferons in the management of chronic myelogenous leukemia. Acta Haematologica. 70-4. PMID 2449026 DOI: 10.1159/000205906 |
0.357 |
|
| 1987 |
Kantarjian HM, Keating MJ, Walters RS, Smith TL, Cork A, McCredie KB, Freireich EJ. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 4: 1748-57. PMID 3783201 DOI: 10.1200/Jco.1986.4.12.1748 |
0.462 |
|
| 1987 |
Keating MJ, Gehan EA, Smith TL, Estey EH, Walters RS, Kantarjian HM, McCredie KB, Freireich EJ. A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 5: 710-21. PMID 3553435 DOI: 10.1200/JCO.1987.5.5.710 |
0.307 |
|
| 1987 |
Kantarjian HM, Keating MJ, Talpaz M, Walters RS, Smith TL, Cork A, McCredie KB, Freireich EJ. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. The American Journal of Medicine. 83: 445-54. PMID 3477958 DOI: 10.1016/0002-9343(87)90754-6 |
0.328 |
|
| 1987 |
Walters RS, Kantarjian HM, Keating MJ, Talpaz M, Childs CC, McCredie KB, Freireich EJ. Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron. Cancer. 60: 1708-12. PMID 3477315 DOI: 10.1002/1097-0142(19871015)60:8<1708::Aid-Cncr2820600803>3.0.Co;2-1 |
0.43 |
|
| 1987 |
Walters RS, Kantarjian HM, Keating MJ, Estey EH, McCredie KB, Freireich EJ. Intensive treatment of acute leukemia in adults 70 years of age and older. Cancer. 60: 149-55. PMID 3474052 DOI: 10.1002/1097-0142(19870715)60:2<149::AID-CNCR2820600204>3.0.CO;2-F |
0.319 |
|
| 1987 |
Keating MJ, Cork A, Broach Y, Smith T, Walters RS, McCredie KB, Trujillo J, Freireich EJ. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leukemia Research. 11: 119-33. PMID 3469482 DOI: 10.1016/0145-2126(87)90017-8 |
0.356 |
|
| 1987 |
Kantarjian HM, Keating MJ, Walters RS, Smith TL, McCredie KB, Freireich EJ. Role of maintenance chemotherapy in acute promyelocytic leukemia. Cancer. 59: 1258-63. PMID 3469011 DOI: 10.1002/1097-0142(19870401)59:7<1258::AID-CNCR2820590705>3.0.CO;2-G |
0.329 |
|
| 1987 |
Dekmezian R, Kantarjian HM, Keating MJ, Talpaz M, McCredie KB, Freireich EJ. The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia. Cancer. 59: 1739-43. PMID 2435399 DOI: 10.1002/1097-0142(19870515)59:10<1739::Aid-Cncr2820591011>3.0.Co;2-2 |
0.383 |
|
| 1987 |
Estey E, Keating MJ, Plunkett WK, McCredie KB, Freireich EJ. Continuous infusion high-dose cytosine arabinoside without anthracyclines as induction and intensification therapy in adults under age 50 with newly diagnosed acute myelogenous leukemia. Seminars in Oncology. 14: 58-63. DOI: 10.5555/Uri:Pii:0093775487900443 |
0.353 |
|
| 1987 |
KANTARJIAN HM, KEATING MJ, McCREDIE KB, WALTERS R, TALPAZ M, SMITH TL, FREIREICH EJ. Old Age Southern Medical Journal. 80: 1228-1232. DOI: 10.1097/00007611-198710000-00007 |
0.337 |
|
| 1986 |
Maddox AM, Keating MJ, Smith TL, Speer J, Cork MA, Trujillo JM, McCredie KB, Freireich EJ. Prognostic factors for survival of 194 patients with low infiltrate leukemia. Leukemia Research. 10: 995-1006. PMID 3747589 DOI: 10.1016/0145-2126(86)90252-3 |
0.302 |
|
| 1986 |
Kantarjian HM, Keating MJ, Walters RS, McCredie KB, Smith TL, Talpaz M, Beran M, Cork A, Trujillo JM, Freireich EJ. Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia. Cancer. 58: 2023-30. PMID 3463397 DOI: 10.1002/1097-0142(19861101)58:9<2023::Aid-Cncr2820580912>3.0.Co;2-H |
0.376 |
|
| 1986 |
Kantarjian HM, Estey EH, Plunkett W, Keating MJ, Walters RS, Iacoboni S, McCredie KB, Freireich EJ. Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia. The American Journal of Medicine. 81: 387-94. PMID 3463209 DOI: 10.1016/0002-9343(86)90287-1 |
0.4 |
|
| 1986 |
Iacoboni SJ, Plunkett W, Kantarjian HM, Estey E, Keating MJ, McCredie KB, Freireich EJ. High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 4: 1079-88. PMID 3459811 DOI: 10.1200/JCO.1986.4.7.1079 |
0.321 |
|
| 1986 |
Kantarjian HM, Keating MJ, Walters RS, Estey EH, McCredie KB, Smith TL, Dalton WT, Cork A, Trujillo JM, Freireich EJ. Acute promyelocytic leukemia. M.D. Anderson Hospital experience. The American Journal of Medicine. 80: 789-97. PMID 3458366 DOI: 10.1016/0002-9343(86)90617-0 |
0.449 |
|
| 1986 |
Lee R, Cabanillas F, Bodey GP, Freireich EJ. A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 4: 1455-61. PMID 2428947 DOI: 10.1200/Jco.1986.4.10.1455 |
0.389 |
|
| 1985 |
Andersson BS, Cogan BM, Keating MJ, Estey EH, McCredie KB, Freireich EJ. Subacute pulmonary failure complicating therapy with high-dose Ara-C in acute leukemia. Cancer. 56: 2181-4. PMID 4052964 DOI: 10.1002/1097-0142(19851101)56:9<2181::Aid-Cncr2820560907>3.0.Co;2-B |
0.362 |
|
| 1985 |
Maddox AM, Johnston DA, Barlogie B, Youness E, Keating M, Freireich EJ. DNA-RNA measurements in patients with acute leukemia undergoing remission induction therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 3: 799-808. PMID 4009216 DOI: 10.1200/Jco.1985.3.6.799 |
0.347 |
|
| 1985 |
Kantarjian HM, Vellekoop L, McCredie KB, Keating MJ, Hester J, Smith T, Barlogie B, Trujillo J, Freireich EJ. Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 3: 192-200. PMID 3855444 DOI: 10.1200/Jco.1985.3.2.192 |
0.423 |
|
| 1985 |
Kantarjian H, Smith T, McCredie K, Keating M, Walters R, Talpaz M, Hester J, Bligham G, Gehan E, Freireich E. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival Blood. 66: 1326-1335. DOI: 10.1182/Blood.V66.6.1326.1326 |
0.441 |
|
| 1985 |
Holmes R, Keating M, Cork A, Broach Y, Trujillo J, Dalton WJ, McCredie K, Freireich E. A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22) Blood. 65: 1071-1078. DOI: 10.1182/BLOOD.V65.5.1071.1071 |
0.323 |
|
| 1984 |
Barlogie B, Johnston DA, Keating M, Spitzer G, Hittelman WN, Nishioki K, Freireich EJ. Evolution of oligoleukemia. Cancer. 53: 2115-24. PMID 6704901 DOI: 10.1002/1097-0142(19840515)53:10<2115::Aid-Cncr2820531021>3.0.Co;2-Y |
0.415 |
|
| 1984 |
Estey EH, Keating MJ, Smith TL, McCredie KB, Legha SS, Walters RS, Bodey GP, Freireich EJ. Prediction of complete remission in patients with refractory acute leukemia treated with AMSA. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2: 102-6. PMID 6583328 DOI: 10.1200/JCO.1984.2.2.102 |
0.337 |
|
| 1984 |
Freireich EJ. Acute leukemia. A prototype of disseminated cancer. Cancer. 53: 2026-33. PMID 6367932 DOI: 10.1002/1097-0142(19840515)53:10<2026::Aid-Cncr2820531004>3.0.Co;2-Q |
0.319 |
|
| 1984 |
Estey E, Maksymiuk A, Smith T, Fainstein V, Keating M, McCredie KB, Freireich EJ, Bodey GP. Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two. Archives of Internal Medicine. 144: 1562-8. PMID 6087753 DOI: 10.1001/Archinte.144.8.1562 |
0.368 |
|
| 1984 |
Freireich E. Nitrogen Mustard Therapy Jama: the Journal of the American Medical Association. 251: 2262. DOI: 10.1001/Jama.1984.03340410070037 |
0.311 |
|
| 1983 |
McCredie KB, Gehan EA, Freireich EJ, Hewlett JS, Coltman CA, Hussein KK, Balcerzak SP, Chen TT. Management of adult acute leukemia a southwest oncology group study Cancer. 52: 958-966. PMID 6883280 DOI: 10.1002/1097-0142(19830915)52:6<958::Aid-Cncr2820520604>3.0.Co;2-Z |
0.447 |
|
| 1983 |
Coltman CA, Freireich EJ, Pendleton O, Bickers JN, Bodey GP, Hewlett JS, McCredie KB. Adult acute leukemia studies utilizing cytarabine: early Southwest Oncology Group trials. Medical and Pediatric Oncology. 173-83. PMID 6761566 DOI: 10.1002/Mpo.2950100717 |
0.355 |
|
| 1983 |
Maddox AM, Keating MJ, Trujillo J, Cork A, Youness E, Ahearn MJ, McCredie KB, Freireich EJ. Philadelphia chromosome-positive adult acute leukemia with monosomy of chromosome number seven: a subgroup with poor response to therapy. Leukemia Research. 7: 509-22. PMID 6578392 DOI: 10.1016/0145-2126(83)90046-2 |
0.316 |
|
| 1983 |
Hug V, Keating M, McCredie K, Hester J, Bodey GP, Freireich EJ. Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count. Cancer. 52: 773-9. PMID 6575857 DOI: 10.1002/1097-0142(19830901)52:5<773::AID-CNCR2820520503>3.0.CO;2-X |
0.309 |
|
| 1983 |
Cabanillas F, Burgess MA, Bodey GP, Freireich EJ. Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type The American Journal of Medicine. 74: 382-388. PMID 6187213 DOI: 10.1016/0002-9343(83)90955-5 |
0.384 |
|
| 1982 |
Feun LG, Gutterman J, Burgess MA, Hersh EM, Mavligit G, McBride CM, Benjamin RS, Richman SP, Murphy WK, Bodey GP, Brown BW, Mountain CF, Leavens ME, Freireich EJ. The natural history of resectable metastatic melanoma (stage IVA melanoma) Cancer. 50: 1656-1663. PMID 7116298 DOI: 10.1002/1097-0142(19821015)50:8<1656::Aid-Cncr2820500833>3.0.Co;2-L |
0.348 |
|
| 1982 |
Keating MJ, Smith TL, Gehan EA, McCredie KB, Bodey GP, Freireich EJ. A prognostic factor analysis for use in development of predictive models for response in adult acute leukemia. Cancer. 50: 457-65. PMID 7093887 DOI: 10.1002/1097-0142(19820801)50:3<457::AID-CNCR2820500313>3.0.CO;2-K |
0.313 |
|
| 1982 |
Cabanillas F, Hagemeister F, Bodey G, Freireich E. IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy Blood. 60: 693-697. DOI: 10.1182/Blood.V60.3.693.Bloodjournal603693 |
0.424 |
|
| 1982 |
Legha S, Keating M, McCredie K, Bodey G, Freireich E. Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults Blood. 60: 484-490. DOI: 10.1182/BLOOD.V60.2.484.484 |
0.35 |
|
| 1981 |
Stewart DJ, Keating MJ, McCredie KB, Smith TL, Youness E, Murphy SG, Bodey GP, Freireich EJ. Natural history of central nervous system acute leukemia in adults. Cancer. 47: 184-96. PMID 7459807 DOI: 10.1002/1097-0142(19810101)47:1<184::Aid-Cncr2820470130>3.0.Co;2-M |
0.385 |
|
| 1981 |
Keating MJ, Smith TL, McCredie KB, Bodey GP, Hersh EM, Gutterman JU, Gehan E, Freireich EJ. A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia. Cancer. 47: 2779-88. PMID 6942906 DOI: 10.1002/1097-0142(19810615)47:12<2779::AID-CNCR2820471204>3.0.CO;2-0 |
0.329 |
|
| 1981 |
McCredie KB, Bodey GP, Freireich EJ, Hester JP, Rodriguez V, Keating MJ. Chemoimmunotherapy of adult acute leukemia. Cancer. 47: 1256-61. PMID 6939477 DOI: 10.1002/1097-0142(19810315)47:6<1256::AID-CNCR2820470605>3.0.CO;2-9 |
0.34 |
|
| 1981 |
Keating M, McCredie K, Benjamin R, Bodey G, Zander A, Smith T, Freireich E. Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP) Blood. 58: 584-591. DOI: 10.1182/Blood.V58.3.584.Bloodjournal583584 |
0.43 |
|
| 1981 |
Cabanillas F, Legha S, Bodey G, Freireich E. Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disorders Blood. 57: 614-616. DOI: 10.1182/BLOOD.V57.3.614.614 |
0.311 |
|
| 1980 |
Legha SS, Keating MJ, Zander AR, McCredie KB, Bodey GP, Freireich EJ. 4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia. Annals of Internal Medicine. 93: 17-21. PMID 6930826 DOI: 10.7326/0003-4819-93-1-17 |
0.433 |
|
| 1980 |
Freireich EJ. Can we afford to treat acute leukemia? The New England Journal of Medicine. 302: 1084-5. PMID 6767979 DOI: 10.1056/Nejm198005083021910 |
0.385 |
|
| 1980 |
Mavlight GM, Stuckey SE, Cabanillas FF, Keating MJ, Tourtellotte WW, Schold SC, Freireich EJ. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination. The New England Journal of Medicine. 303: 718-22. PMID 6157089 DOI: 10.1056/Nejm198009253031302 |
0.366 |
|
| 1980 |
Legha SS, Buzdar AU, Smith TL, Hortobagyi GN, Swenerton KD, Blumenschein GR, Gehan EA, Bodey GP, Freireich EJ. Complete remissions in metastatic breast cancer treated with combination drug therapy. Annals of Internal Medicine. 91: 847-52. PMID 517883 DOI: 10.7326/0003-4819-91-6-847 |
0.377 |
|
| 1980 |
BEDIKIAN AY, VALDIVIESO M, HEILBRUN LK, WITHERS RH, BODEY GP, FREIREICH EJ. Glycerol Southern Medical Journal. 73: 1210-1214. DOI: 10.1097/00007611-198009000-00012 |
0.348 |
|
| 1979 |
Bodey GP, McCredie KB, Keating MJ, Freireich EJ. Treatment of acute leukemia in protected environment units. Cancer. 44: 431-6. PMID 113075 DOI: 10.1002/1097-0142(197908)44:2<431::AID-CNCR2820440209>3.0.CO;2-4 |
0.333 |
|
| 1979 |
Bodey GP, Rodriguez V, Cabanillas F, Freireich EJ. Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remission. The American Journal of Medicine. 66: 74-81. PMID 84532 DOI: 10.1016/0002-9343(79)90485-6 |
0.393 |
|
| 1979 |
Litam J, Cabanillas F, Smith T, Bodey G, Freireich E. Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis Blood. 54: 1249-1257. DOI: 10.1182/Blood.V54.6.1249.Bloodjournal5461249 |
0.307 |
|
| 1979 |
Hester J, McBride CM, McCredie KB, Freireich EJ. Splenectomy in chronic myelogenous leukemia (CML) patients: A long term follow up International Journal of Radiation Oncology*Biology*Physics. 5: 66. DOI: 10.1016/0360-3016(79)91046-0 |
0.33 |
|
| 1979 |
Buzdar AU, Blumenschein GR, Tashima CK, Hortobagyi GN, Gutterman JU, Hersh EM, Freireich E, Smith TL, Gehan EA, Campos LT, Wheeler WL. Postoperative Adjuvant Chemotherapy With Fluorouracil, Doxorubicin, Cyclophosphamide, and BCG Vaccine: A Follow-up Report Jama: the Journal of the American Medical Association. 242: 1509-1513. DOI: 10.1001/Jama.1979.03300140025017 |
0.359 |
|
| 1978 |
Coltman CA, Bodey GP, Hewlett JS, Haut A, Bickers J, Balcerzak SP, Costanzi JJ, Freireich EJ, McCredie KB, Groppe C, Smith TL, Gehan EA. Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicin. Archives of Internal Medicine. 138: 1342-8. PMID 686922 DOI: 10.1001/Archinte.138.9.1342 |
0.395 |
|
| 1978 |
Rodriguez V, Bodey GP, Freireich EJ, McCredie KB, Gutterman JU, Keating MJ, Smith TL, Gehan EA. Randomized trial of protected environment--prophylactic antibiotics in 145 adults with acute leukemia. Medicine. 57: 253-66. PMID 642793 DOI: 10.1097/00005792-197805000-00005 |
0.397 |
|
| 1978 |
Yap BS, McCredie KB, Benjamin RS, Bodey GP, Freireich EJ. Refractory acute leukaemia in adults treated with sequential colaspase and high-dose methotrexate. British Medical Journal. 2: 791-3. PMID 279387 DOI: 10.1136/Bmj.2.6140.791 |
0.388 |
|
| 1977 |
Hart JS, George SL, Frei E, Bodey GP, Nickerson RC, Freireich EJ. Prognotic significance of pretreatment proliferative activity in adult acute leukemia. Cancer. 39: 1603-17. PMID 265746 DOI: 10.1002/1097-0142(197704)39:4<1603::AID-CNCR2820390435>3.0.CO;2-8 |
0.349 |
|
| 1977 |
Rodriguez V, Cabanillas F, Burgess M, McKelvey E, Valdivieso M, Bodey G, Freireich E. Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma Blood. 49: 325-333. DOI: 10.1182/Blood.V49.3.325.Bloodjournal493325 |
0.399 |
|
| 1976 |
Bodey GP, Freireich EJ, McCredie KB, Rodriguez V, Burgess MA, Frei E. Combinations of arabinosyl cytosine and 6-thioguanine for treatment of adults with acute leukemia. Medical and Pediatric Oncology. 1: 29-35. PMID 1066520 DOI: 10.1002/MPO.2950010106 |
0.329 |
|
| 1976 |
Chang HY, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ. Causes of death in adults with acute leukemia. Medicine. 55: 259-68. PMID 1063911 DOI: 10.1097/00005792-197605000-00005 |
0.303 |
|
| 1976 |
McCredie KB, Freireich EJ, Bodey GP, Burgess MA, Whitecar JP, Smith TL. A study of intermittent alternating drug program reinduction therapy on the frequency and duration of response in adult acute leukemia. Medical and Pediatric Oncology. 2: 309-18. PMID 979915 DOI: 10.1002/MPO.2950020312 |
0.318 |
|
| 1976 |
Gutterman JU, Cardenas JO, Blumenschein GR, Hortobagyi G, Burgess MA, Livingston RB, Mavligit GM, Freireich EJ, Gottlieb JA, Hersh EM. Chemoimmunotherapy of advanced breast cancer: Prolongation of remission and survival with BCG British Medical Journal. 2: 1222-1225. PMID 791447 DOI: 10.1136/Bmj.2.6046.1222 |
0.391 |
|
| 1976 |
Bodey GP, Rodriguez V, McCredie KB, Freireich EJ. Early consolidation chemotherapy for adults with acute leukemia in remission. Medical and Pediatric Oncology. 2: 299-307. PMID 790146 DOI: 10.1002/MPO.2950020311 |
0.31 |
|
| 1976 |
Spitzer G, Dicke K, Gehan E, Smith T, McCredie K, Barlogie B, Freireich E. A simplified in vitro classification for prognosis in adult acute leukemia: the application of in vitro results in remission-predictive models Blood. 48: 795-807. DOI: 10.1182/Blood.V48.6.795.Bloodjournal486795 |
0.38 |
|
| 1976 |
Gutterman JU, Mavligit GM, Burgess MA, Cardenas JO, Blumenschein GR, Gottlieb JA, McBride CM, McCredie KB, Bodey GP, Rodriguez V, Freireich EJ, Hersh EM. Immunotherapy of breast cancer, malignant melanoma, and acute leukemia with BCG: Prolongation of disease free interval and survival Cancer Immunology Immunotherapy. 1: 99-107. DOI: 10.1007/BF00205301 |
0.338 |
|
| 1976 |
Freireich EJ. Grounds for Optimism in Treating Acute Granulocytic Leukemia (Adult Acute Leukemia) Archives of Internal Medicine. 136: 1375. DOI: 10.1001/Archinte.1976.03630120027011 |
0.346 |
|
| 1976 |
Freireich EJ. Developmental therapy in adult acute leukemia Archives of Internal Medicine. 136: 1417-1421. DOI: 10.1001/Archinte.136.12.1417 |
0.396 |
|
| 1975 |
McCredie KB, Hester JP, Freireich EJ, Brittin GM, Vallejos C. Platelet and leukocyte transfusions in acute leukemia. Human Pathology. 5: 699-708. PMID 4607955 DOI: 10.1016/S0046-8177(74)80040-7 |
0.407 |
|
| 1975 |
Rodriguez V, Bodey GP, McCredie KB, Freireich EJ, Minow RA, Casey JH, Luna M. Combination 6-mercaptopurine-adriamycin in refractory adult acute leukemia. Clinical Pharmacology and Therapeutics. 18: 462-6. PMID 1100309 DOI: 10.1002/cpt1975184462 |
0.333 |
|
| 1975 |
Leventhal BG, Levine AS, Graw RG, Simon R, Freireich EJ, Henderson ES. Long-term second remissions in acute lymphatic leukemia. Cancer. 35: 1136-40. PMID 1054285 DOI: 10.1002/1097-0142(197504)35:4<1136::Aid-Cncr2820350417>3.0.Co;2-T |
0.39 |
|
| 1975 |
Freireich EJ. Approaches to Local Immunotherapy Jama: the Journal of the American Medical Association. 234: 1258. DOI: 10.1001/Jama.1975.03260250050031 |
0.304 |
|
| 1974 |
Gutterman JU, Mavligit G, Gottlieb JA, Burgess MA, McBride CE, Einhorn L, Freireich EJ, Hersh EM. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. The New England Journal of Medicine. 291: 592-7. PMID 4851001 DOI: 10.1056/Nejm197409192911202 |
0.394 |
|
| 1974 |
Hersh EM, Gutterman JU, Mavligit GM, McCredie KB, Burgess MA, Matthews A, Freireich EJ. Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia. The Journal of Clinical Investigation. 54: 401-8. PMID 4527189 DOI: 10.1172/JCI107775 |
0.336 |
|
| 1974 |
Bodey GP, Hewlett JS, Coltman CA, Rodriguez V, Freireich EJ. Therapy of adult acute leukemia with daunorubicin and L-asparaginase. Cancer. 33: 626-30. PMID 4521886 DOI: 10.1002/1097-0142(197403)33:3<626::Aid-Cncr2820330306>3.0.Co;2-5 |
0.31 |
|
| 1974 |
Bickers JN, Gehan EA, Freireich EJ, Coltman CA, Wilson HE, Hewlett JS, Stuckey WJ, Van Slyck EJ. Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response. Archives of Internal Medicine. 133: 251-9. PMID 4521467 DOI: 10.1001/Archinte.133.2.251 |
0.33 |
|
| 1973 |
Freireich EJ. Research contributions to combination chemotherapy. Jama. 222: 1169. PMID 4678058 DOI: 10.1001/Jama.1972.03210090049021 |
0.403 |
|
| 1973 |
Rodriguez V, Bodey GP, Freireich EJ. Combination chemotherapy for lymphomas and leukemias. Disease-a-Month : Dm. 1-40. PMID 4571062 DOI: 10.1016/S0011-5029(73)80012-4 |
0.359 |
|
| 1973 |
Gutterman JU, Rossen RD, Butler WT, McCredie KB, Bodey GP, Freireich EJ, Hersh EM. Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. The New England Journal of Medicine. 288: 169-75. PMID 4565852 DOI: 10.1056/Nejm197301252880401 |
0.384 |
|
| 1972 |
Bodey GP, Gehan EA, Freireich EJ, Frei E. Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia. The American Journal of the Medical Sciences. 262: 138-51. PMID 5142054 DOI: 10.1097/00000441-197109000-00001 |
0.327 |
|
| 1972 |
Freireich EJ. Research Contributions to Supportive Measures for Cancer Chemotherapy Jama: the Journal of the American Medical Association. 222: 1173. DOI: 10.1001/Jama.1972.03210090053028 |
0.351 |
|
| 1971 |
Hart JS, Trujillo JM, Freireich EJ, George SL, Frei E. Cytogenetic studies and their clinical correlates in adults with acute leukemia. Annals of Internal Medicine. 75: 353-60. PMID 5284907 DOI: 10.7326/0003-4819-75-3-353 |
0.337 |
|
| 1971 |
Freireich EJ. Leukemia and Lymphoma. Archives of Internal Medicine. 127: 1142. DOI: 10.1001/Archinte.1971.00310180158031 |
0.339 |
|
| 1970 |
WHANG-PENG J, HENDERSON ES, KNUTSEN T, FREIREICH EJ, GART JJ. Cytogenetic Studies in Acute Myelocytic Leukemia with Special Emphasis on the Occurrence of Ph1 Chromosome Blood. 36: 448-457. DOI: 10.1182/Blood.V36.4.448.448 |
0.373 |
|
| 1970 |
HARRIS J, FREIREICH EJ. In Vitro Growth of Myeloid Colonies from Bone Marrow of Patients with Acute Leukemia in Remission Blood. 35: 61-63. DOI: 10.1182/Blood.V35.1.61.61 |
0.356 |
|
| 1969 |
Bodey GP, DeJongh D, Isassi A, Freireich EJ. Hypersplenism due to disseminated candidiasis in a patient with acute leukemia. Cancer. 24: 417-20. PMID 5256261 DOI: 10.1002/1097-0142(196908)24:2<417::AID-CNCR2820240226>3.0.CO;2-2 |
0.31 |
|
| 1969 |
Whang-Peng J, Freireich EJ, Oppenheim JJ, Frei E, Tjio JH. Cytogenetic Studies in 45 Patients With Acute Lymphocytic Leukemia Journal of the National Cancer Institute. 42: 881-897. DOI: 10.1093/Jnci/42.6.881 |
0.436 |
|
| 1968 |
Bodey GP, Hersh EM, Freireich EJ. Recurrent Listeria monocytogenes meningitis in a patient with acute leukemia. Cancer. 21: 619-22. PMID 5238819 DOI: 10.1002/1097-0142(196804)21:4<619::Aid-Cncr2820210413>3.0.Co;2-B |
0.395 |
|
| 1968 |
Bodey GP, Hart J, Freireich EJ. Prolonged survival of a leukemic patient in a protected environment. The American Journal of the Medical Sciences. 256: 112-21. PMID 4970510 DOI: 10.1097/00000441-196808000-00007 |
0.341 |
|
| 1966 |
Johnson RE, Zelen M, Freireich EJ. Evaluation of human acute leukemia data using a murine leukemia model system Cancer. 19: 481-484. PMID 5933573 DOI: 10.1002/1097-0142(196604)19:4<481::Aid-Cncr2820190404>3.0.Co;2-P |
0.353 |
|
| 1966 |
Karon M, Freireich EJ, Frei E, Taylor R, Wolman IJ, Djerassi I, Lee SL, Sawitsky A, Hananian J, Selawry O, James D, George P, Patterson RB, Burgert O, Haurani FI, et al. The role of vincristine in the treatment of childhood acute leukemia. Clinical Pharmacology and Therapeutics. 7: 332-9. PMID 5327856 DOI: 10.1002/Cpt196673332 |
0.328 |
|
| 1966 |
Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Annals of Internal Medicine. 64: 328-40. PMID 5216294 DOI: 10.7326/0003-4819-64-2-328 |
0.351 |
|
| 1966 |
Flatow FA, Freireich EJ. Effect of splenectomy on the response to platelet transfusion in three patients with aplastic anemia. The New England Journal of Medicine. 274: 242-8. PMID 5216246 DOI: 10.1056/Nejm196602032740503 |
0.334 |
|
| 1966 |
Morse EE, Freireich EJ, Carbone PP, Bronson W, Frei E. The Transfusion of Leukocytes from Donors with Chronic Myelocytic Leukemia to Patients with Leukopenia Transfusion. 6: 183-192. DOI: 10.1111/J.1537-2995.1966.Tb04723.X |
0.378 |
|
| 1966 |
Morse EE, Carbone PP, Freireich EJ, Bronson W, Kliman A. Repeated Leukapheresis of Patients with Chronic Myelocytic Leukemia Transfusion. 6: 175-182. DOI: 10.1111/J.1537-2995.1966.Tb04722.X |
0.394 |
|
| 1966 |
Levin RH, Whang J, Carbone PP, Freireich EJ. Erythroid homograft following transfusion in a patient with acute leukemia Transplantation. 4: 348. DOI: 10.1097/00007890-196605000-00029 |
0.437 |
|
| 1965 |
Nies BA, Thomas LB, Freireich EJ. Meningeal leukemia. A follow‐up study Cancer. 18: 546-553. PMID 14278887 DOI: 10.1002/1097-0142(196505)18:5<546::Aid-Cncr2820180503>3.0.Co;2-E |
0.381 |
|
| 1965 |
Nies BA, Malmgren RA, Chu EW, Del Vecchio PR, Thomas LB, Freireich EJ. Cerebrospinal fluid cytology in patients with acute leukemia Cancer. 18: 1385-1391. PMID 5215032 DOI: 10.1002/1097-0142(196511)18:11<1385::Aid-Cncr2820181102>3.0.Co;2-9 |
0.375 |
|
| 1965 |
FREI E, KARON M, LEVIN RH, FREIREICH EJ, TAYLOR RJ, HANANIAN J, SELAWRY O, HOLLAND JF, HOOGSTRATEN B, WOLMAN IJ, ABIR E, SAWITSKY A, LEE S, MILLS SD, BURGERT EO, et al. The Effectiveness of Combinations of Antileukemic Agents in Inducing and Maintaining Remission in Children with Acute Leukemia Blood. 26: 642-656. DOI: 10.1182/Blood.V26.5.642.642 |
0.42 |
|
| 1965 |
LEVIN RH, WHANG J, CARBONE PP, FREIREICH EJ. Erythroid Homograft Following Leukocyte Transfusion in a Patient with Acute Leukemia Blood. 26: 587-596. DOI: 10.1182/Blood.V26.5.587.587 |
0.41 |
|
| 1965 |
NIES BA, BODEY GP, THOMAS LB, BRECHER G, FREIREICH EJ. The Persistence of Extramedullary Leukemic Infiltrates during Bone Marrow Remission of Acute Leukemia Blood. 26: 133-141. DOI: 10.1182/Blood.V26.2.133.133 |
0.349 |
|
| 1964 |
Bodey GP, Nies BA, Mohberg NR, Freireich EJ. Use of Gamma Globulin in Infection in Acute-Leukemia Patients. Jama. 190: 1099-1102. PMID 14212297 DOI: 10.1001/Jama.1964.03070260011002 |
0.363 |
|
| 1964 |
Fishbein WN, Carbone PP, Freireich EJ, Misra D, Frei E. Clinical trials of hydroxyurea in patients with cancer and leukemia Clinical Pharmacology and Therapeutics. 5: 574-580. PMID 14209774 DOI: 10.1002/Cpt196455574 |
0.456 |
|
| 1964 |
Levin RH, Freireich EJ, Chappell W. Effect of Storage up to 48 Hours on Response to Transfusions of Platelet Rich Plasma Transfusion. 4: 251-256. PMID 14177375 DOI: 10.1111/J.1537-2995.1964.Tb02867.X |
0.302 |
|
| 1963 |
RIESELBACH RE, MORSE EE, RALL DP, FREI E, FREIREICH EJ. Intrathecal aminopterin therapy of meningeal leukemia. Archives of Internal Medicine. 111: 620-30. PMID 13973810 DOI: 10.1001/Archinte.1963.03620290086011 |
0.413 |
|
| 1963 |
Freireich EJ, Gehan E, Frei E, Schroeder LR, Wolman IJ, Anbari R, Burgert EO, Mills SD, Pinkel D, Selawry OS, Moon JH, Gendel BR, Spurr CL, Storrs R, Haurani F, et al. The Effect of 6-Mercaptopurine on the Duration of Steroid-induced Remissions in Acute Leukemia: A Model for Evaluation of Other Potentially Useful Therapy Blood. 21: 699-716. DOI: 10.1182/Blood.V21.6.699.699 |
0.412 |
|
| 1963 |
LEVIN RH, BRITTIN GM, FREIREICH EJ. Different Patterns of Remisson in Acute Myelocytic Leukemia Blood. 21: 689-698. DOI: 10.1182/Blood.V21.6.689.689 |
0.341 |
|
| 1962 |
Fallon HJ, Frei E, Freireich EJ. Correlations of the biochemical and clinical effects of 6-azauridine in patients with leukemia The American Journal of Medicine. 33: 526-537. DOI: 10.1016/0002-9343(62)90263-2 |
0.397 |
|
| 1961 |
Frei E, Freireich EJ, Gehan E, Pinkel D, Holland JF, Selawry O, Haurani F, Spurr CL, Hayes DM, James GW, Rothberg H, Sodee DB, Rundles RW, Schroeder LR, Hoogstraten B, et al. Studies of Sequential and Combination Antimetabolite Therapy in Acute Leukemia: 6-Mercaptopurine and Methotrexate Blood. 18: 431-454. DOI: 10.1182/Blood.V18.4.431.431 |
0.398 |
|
| 1960 |
Moore EW, Thomas LB, Shaw RK, Freireich EJ. The Central Nervous System in Acute Leukemia: A Postmortem Study of 117 Consecutive Cases, with Particular Reference to Hemorrhages, Leukemic Infiltrations, and the Syndrome of Meningeal Leukemia A.M.a Archives of Internal Medicine. 105: 451-468. PMID 14423837 DOI: 10.1001/Archinte.1960.00270150105011 |
0.334 |
|
| 1960 |
Shaw RK, Moore EW, Freireich EJ, Thomas LB. Meningeal leukemia: A syndrome resulting from increased intracranial pressure in patients with acute leukemia Neurology. 10: 823-823. DOI: 10.1212/Wnl.10.9.823 |
0.355 |
|
| 1960 |
FREIREICH EJ, FREI E, HOLLAND JF, PINKEL D, SELAWRY O, ROTHBERG H, HAURANI F, TAYLOR R, GEHAN EA. Evaluation of a New Chemotherapeutic Agent in Patients with "Advanced Refractory" Acute Leukemia. Studies of 6-Azauracil Blood. 16: 1268-1278. DOI: 10.1182/Blood.V16.3.1268.1268 |
0.442 |
|
| 1959 |
FRITZ RD, FORKNER CE, FREIREICH EJ, FREI E, THOMAS LB. The association of fatal intracranial hemorrhage and blastic crisis in patients with acute leukemia The New England Journal of Medicine. 261: 59-64. PMID 13666978 DOI: 10.1056/Nejm195907092610202 |
0.407 |
|
| 1958 |
FREI E, HOLLAND JF, SCHNEIDERMAN MA, PINKEL D, SELKIRK G, FREIREICH EJ, SILVER RT, GOLD GL, REGELSON W. A Comparative Study of Two Regimens of Combination Chemotherapy in Acute Leukemia Blood. 13: 1126-1148. DOI: 10.1182/BLOOD.V13.12.1126.1126 |
0.362 |
|
| Show low-probability matches. |